The utility of PD-L1 as a prognostic marker in pancreatic ductal adenocarcinoma (PDAC).

被引：0
|
作者：
Wu, Linda
Fulop, Daniel Jeremy
Rudshteyn, Michelle
Shah, Nagma
Hill-Oliva, Michael
Sohval, Sophie
Gandhi, Sonal
Chowdhury, Nobel
Debnath, Neha
Cohen, Deirdre Jill
机构：
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Mt Sinai Morningside West, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Morningside West, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
753
引用
收藏
页码：753 / 753
页数：1
相关论文
共 50 条
  • [31] Clinical utility of circulating tumor DNA (ctDNA) in resectable pancreatic ductal adenocarcinoma (PDAC)
    Wong, Hui -Li
    Bushell, Kevin
    Karasinska, Joanna
    Arthur, Sarah
    Morin, Ryan
    Schaeffer, David F.
    Renouf, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Mucin-1 (MUC-1) protein a prognostic marker for pancreatic ductal adenocarcinoma (PDAC): results from the CONKO-001 study
    Striefler, J. K.
    Sinn, M.
    Lohneis, P.
    Bischoff, S.
    Pelzer, U.
    Stieler, J.
    Oettle, H.
    Denkert, C.
    Riess, H.
    Sinn, B., V
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 86 - 86
  • [33] PD-L1 expression and deficient mismatch repair in ductal adenocarcinoma of the prostate
    Lindh, Claes
    Kis, Lorand
    Delahunt, Brett
    Samaratunga, Hemamali
    Yaxley, John
    Wiklund, Nils Peter
    Clements, Mark
    Egevad, Lars
    APMIS, 2019, 127 (08) : 554 - 560
  • [34] Gene expression analysis demonstrates prognostic subtypes in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Wong, Hui-li
    Karasinska, Joanna M.
    Jones, Martin
    Eirew, Peter
    Schrader, Kasmintan
    Lim, Howard
    Shen, Yaoqing
    Jones, Steven
    Yip, Stephen
    Laskin, Janessa
    Marra, Marco
    Schaeffer, David F.
    Renouf, Daniel J.
    CANCER RESEARCH, 2016, 76
  • [35] Prognostic value of the Memorial Sloan Kettering (MSK) prognostic score (MPS) in pancreatic ductal adenocarcinoma (PDAC).
    Lebenthal, Justin
    Zheng, Junting
    Glare, Paul A.
    O'Reilly, Eileen Mary
    Epstein, Andrew S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31)
  • [36] The prognostic significance of exosomal marker (CD63) expression using immunohistochemistry (IHC) in patients with pancreatic ductal adenocarcinoma (PDAC).
    Khushman, Moh'd M.
    Bhardwaj, Arun
    Patel, Girijesh K.
    Laurini, Javier
    Roveda, Kelly
    Donnell, Robert
    Sherling, Kelley
    Case, Brittany
    Tan, Marcus Chuan Beng
    Thompson, Lee W.
    Nelson, Cindy
    Wyatt, Mary
    Singh, Seema
    Taylor, William R.
    Singh, Ajay
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] PD-L1 Expression on Cell Block Preparations of Pancreatic Adenocarcinoma
    Costa, Victoria
    Kim, David
    Johncilla, Melanie
    Goyal, Abha
    Rao, Rema
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 : S94 - S95
  • [38] PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker
    Dell'Aquila, Marco
    Granitto, Alessia
    Martini, Maurizio
    Capodimonti, Sara
    Cocomazzi, Alessandra
    Musarra, Teresa
    Fiorentino, Vincenzo
    Pontecorvi, Alfredo
    Lombardi, Celestino Pio
    Fadda, Guido
    Pantanowitz, Liron
    Larocca, Luigi Maria
    Rossi, Esther Diana
    CANCER CYTOPATHOLOGY, 2020, 128 (03) : 177 - 189
  • [39] PROGNOSTIC UTILITY OF PD-L1 IN SQUAMOUS CELL CARCINOMA OF THE BLADDER
    Owyong, Michael
    Lotan, Yair
    Kapur, Payal
    Panwar, Vandana
    Lee, Thomas K.
    Zi, Xiaolin
    Martin, Jeremy W.
    Mosbah, Ahmed
    Abol-Enein, Hassan
    Ghoneim, Mohamed
    Youssef, Ramy F.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1039 - E1040
  • [40] THE INVESTIGATION OF PD-L1 EXPRESSION AS A PROGNOSTIC MARKER FOR UTERINE SARCOMA
    Sukhin, V. S.
    Danyliuk, S. V.
    Sukhina, O. N.
    Zadnepryanniy, A. Z.
    Lindquist, D.
    Hermelin, H.
    Tarjan, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 568 - 568
12345